- Home
- RXRX vs NMRK Comparison
RXRX vs NMRK Comparison
Compare RXRX & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- NMRK
- Stock Information
- Founded
- RXRX 2013
- NMRK 1929
- Country
- RXRX United States
- NMRK United States
- Employees
- RXRX N/A
- NMRK N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- NMRK Real Estate
- Sector
- RXRX Health Care
- NMRK Finance
- Exchange
- RXRX Nasdaq
- NMRK Nasdaq
- Market Cap
- RXRX 2.0B
- NMRK 2.2B
- IPO Year
- RXRX 2021
- NMRK 2017
- Fundamental
- Price
- RXRX $6.49
- NMRK $13.59
- Analyst Decision
- RXRX Buy
- NMRK Strong Buy
- Analyst Count
- RXRX 5
- NMRK 5
- Target Price
- RXRX $7.00
- NMRK $16.25
- AVG Volume (30 Days)
- RXRX 34.3M
- NMRK 1.2M
- Earning Date
- RXRX 08-07-2025
- NMRK 07-30-2025
- Dividend Yield
- RXRX N/A
- NMRK 0.88%
- EPS Growth
- RXRX N/A
- NMRK 81.01
- EPS
- RXRX N/A
- NMRK 0.38
- Revenue
- RXRX $59,790,000.00
- NMRK $2,857,497,000.00
- Revenue This Year
- RXRX $23.85
- NMRK $13.78
- Revenue Next Year
- RXRX $43.06
- NMRK $9.47
- P/E Ratio
- RXRX N/A
- NMRK $35.95
- Revenue Growth
- RXRX 29.32
- NMRK 14.48
- 52 Week Low
- RXRX $3.79
- NMRK $9.65
- 52 Week High
- RXRX $12.36
- NMRK $16.10
- Technical
- Relative Strength Index (RSI)
- RXRX 66.22
- NMRK 72.22
- Support Level
- RXRX $5.13
- NMRK $12.06
- Resistance Level
- RXRX $7.14
- NMRK $12.63
- Average True Range (ATR)
- RXRX 0.49
- NMRK 0.33
- MACD
- RXRX 0.10
- NMRK 0.09
- Stochastic Oscillator
- RXRX 69.30
- NMRK 97.77
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About NMRK Newmark Group Inc.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.